AC Immune S.A. (ACIU) vs OraSure Technologies, Inc. (OSUR)

A side-by-side comparison of AC Immune S.A. and OraSure Technologies, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ACIU vs OSUR

growth of $100 · dividends reinvested · last 10y
ACIU -83.1% (-16.3%/yr)OSUR -48.7% (-6.5%/yr)OSUR compounded faster over this window
0100200300Start $10020182020202220242026$17$51
ACIU OSUR

ACIU vs OSUR: by the numbers

  • •OSUR is the larger company ($260M vs $256M market cap).
  • •Both run net losses; OSUR's is the smaller (-43.70% vs -249.94% net margin).
  • •Both shrank revenue over the past five years; OSUR's decline was smaller (-13.12% vs -23.70% CAGR).

Metrics side by side

Valuation

MetricACIUOSUR
P/S ratio11.822.31
P/B ratio5.890.82

Profitability

MetricACIUOSUR
Gross margin100.00%41.38%
Operating margin-1927.32%-59.23%
Net margin-249.94%-43.70%
ROE-124.67%-15.46%
ROIC-89.43%-15.00%

Growth (annualized)

MetricACIUOSUR
Revenue CAGR (5Y)-23.70%-13.12%
Total return CAGR (5Y)-16.03%-17.56%

Frequently asked

Which has grown faster, ACIU or OSUR?
Neither grew: over the past five years both shrank revenue, with OSUR's decline the smaller — ACIU at a -23.70% CAGR versus OSUR at -13.12%.
How have ACIU and OSUR total returns compared?
Over the past 10 years, ACIU delivered -16.61% and OSUR delivered -6.51% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.